Matthew Engel

This year I organized a very exciting panel discussion on private and public equity investment in the biotech and pharmaceutical industries. After discussing the idea with several friends and colleagues, we were able to invite several very interesting speakers with diverse backgrounds and experience in consulting, venture capital, investment banking, business development, and management. Both Bryan Czyzewski and Peter Shapiro helped me brainstorm and conceptualize the event. Eric Vieira also gave alot of constructive feedback during the planning process and offered both much needed advice and support. I would like to especially thank Connecticut Innovations for generously sponsoring the networking reception following our panel discussion. Connecticut Innovations is an evergreen fund which was started by the State of Connecticut initially with $65 million in capital. Their far-reaching investments include drug development companies, medical devices, e-commerce companies, wind turbine developers and other IT and software designers. The event will be held at 1 Chase Manhattan Plaza on the 60th floor at JPMorgan Chase. Hope to see you there!

The FOBIP Alumni Network Executive Committee, New York State Center for Biotechnology, JPMorgan Chase & Co., and Connecticut Innovations Present:

Financing Biotech in 2021

Date: Tuesday, May 3rd, 2011 at 6:30PM Location: 1 Chase Manhattan Plaza, The 60th Floor, Boardroom Agenda: 6:30 – 8:00PM Introductions & Panel Discussion 8:00 – 9:00PM Networking Reception – Sponsored by Connecticut Innovations RSVP Online Required: Click Here (A $10 donation is suggested to support future events) Must RSVP 24hrs in advance to be admitted

 

• Moderator
  

  Stephen Davis

  Partner, Goodwin Procter, LLC

• Panelists
  

  Milena Adamian		Director, Life Sciences Angel Network
  Noah Kroloff		Partner, NGN Capital
  Jennifer Friel Goldstein		Director, Pfizer Venture Investments
  Philip Ross		Executive Director, JPMorgan Healthcare Investment Banking Group
  Daniel Wagner		Director, Investments, Connecticut Innovations

Executive Summary

The goal of this event is to discuss some of the various sources of capital available to emerging pharma and biotech companies and the current trends affecting the market. We have established a panel of investors ranging from angels to investment bankers who will explain their role in financing companies in the healthcare sector. The panel discussion will touch on current technologies attracting investment, promising new sectors, selection mechanisms for targeting companies for investment, factors contributing to successful exits, and upcoming challenges facing the industry in the future. Click Here for Speaker’s Bios

Thank You to Our Sponsors and Supporters!

About the Organizers: The FOBIP Alumni Network is an established, non-profit, all volunteer, industry focused biotech club. It is exclusively composed of young professionals and graduate students from the biomedical sciences who have completed the Fundamentals of the Bioscience Industry Program (FOBIP). The program is taught by industry executives focusing on intellectual property, entrepreneurship, FDA regulations, finance and venture capital in the healthcare sector. The goal of our Alumni Network is to provide educational seminars, industry outreach, and networking opportunities for our members, guests, and followers.